AP Chief Minister YS Rajasekhara Reddy compliments Dr Krishna M Ella.

Bharat Biotech has achieved another milestone. It is the first pharma-biotech company in India to have got the Korean Food & Drugs Administration (KFDA) approval for its manufacturing facility. With this approval Bharat Biotech can now manufacture and export human vaccines to Korea, which is one of the regulated markets in the world for pharmaceuticals. 

“Bharat Biotech's approval by KFDA will create a level playing field and help reposition Indian entry into global markets in the sphere of injectables (Small Volume Parentals). So far very few Indian companies have been successful in manufacturing and exporting injectables to the US and Europe,� remarked Dr Krishna M Ella, chairman and managing director, Bharat Biotech. Citing this development as propitious, Dr Ella said “The only countries around the globe with regulated markets are the US, Europe, Korea and Japan.� “Such developments go a long way in strengthening our credibility.�